CompletedNot Applicable

RE-BLEED: A Digital Platform for Identifying Bleeding Patients - a Feasibility Study

United Kingdom40 participantsStarted 2021-10-01

Plain-language summary

The RE-BLEED feasibility study aims to develop and test a real-time digital platform, whereby bleeding patients in-hospital can be identified and approached for their consent to participate in future research studies.

Who can participate

Age range16 Years – 110 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Retrospective cohort: * Adults aged between 16 and 110 * Admitted to hospital (Oxford University Hospitals NHS Foundation Trust) or attended the emergency department between 1/3/2011 to 31/8/2023 Prospective cohort: * Adults aged between 16 and 110 * Admitted to hospital (Oxford University Hospitals NHS Foundation Trust) or attended the emergency department between 1/10/2021 to 31/8/2023 Exclusion Criteria: Both retrospective and prospective cohorts: * Patients who inform us directly that they do not wish their records used in this research study * Patients who have completed the NHS Opt-out.

What they're measuring

Recruitment rate

Timeframe: Within 3 months from start of recruitment

Trial details

NCT IDNCT05608577

SponsorUniversity of Oxford

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-02-18

View on ClinicalTrials.gov More Hemorrhage trials